FDA Inspection 1144217 — AltaSciences Clinical Los Angeles Inc.

AltaSciences Clinical Los Angeles Inc. — FEI 3006237846

The FDA completed an inspection of AltaSciences Clinical Los Angeles Inc. on June 18, 2021 in Cypress, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 18, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cypress, CA (United States)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
745921 CFR 312.57(a)Records of receipt, shipment, disposition
756021 CFR 312.60FD-1572, protocol compliance